Raunio H - Search Results

1

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes.

Raunio H, Kuusisto M, Juvonen RO, Pentikäinen OT. Raunio H, et al. Front Pharmacol. 2015 Jun 12;6:123. doi: 10.3389/fphar.2015.00123. eCollection 2015. Front Pharmacol. 2015. PMID: 26124721 Free PMC article. Review.

2

Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes.

Juvonen RO, Ahinko M, Huuskonen J, Raunio H, Pentikäinen OT. Juvonen RO, et al. Among authors: raunio h. Xenobiotica. 2019 Sep;49(9):1015-1024. doi: 10.1080/00498254.2018.1530399. Epub 2018 Nov 29. Xenobiotica. 2019. PMID: 30272491

3

Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.

Kumpulainen H, Mähönen N, Laitinen ML, Jaurakkajärvi M, Raunio H, Juvonen RO, Vepsäläinen J, Järvinen T, Rautio J. Kumpulainen H, et al. Among authors: raunio h. J Med Chem. 2006 Feb 9;49(3):1207-11. doi: 10.1021/jm0510124. J Med Chem. 2006. PMID: 16451086

4

Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.

Salminen KA, Meyer A, Jerabkova L, Korhonen LE, Rahnasto M, Juvonen RO, Imming P, Raunio H. Salminen KA, et al. Among authors: raunio h. Phytomedicine. 2011 Apr 15;18(6):533-8. doi: 10.1016/j.phymed.2010.08.012. Epub 2010 Sep 20. Phytomedicine. 2011. PMID: 20851588

5

Design, synthesis, and evaluation of novel cyclic phosphates of 5-aminosalicylic acid as cytochrome p450-activated prodrugs.

Huttunen KM, Tani N, Juvonen RO, Raunio H, Rautio J. Huttunen KM, et al. Among authors: raunio h. Mol Pharm. 2013 Feb 4;10(2):532-7. doi: 10.1021/mp300330v. Epub 2012 Aug 31. Mol Pharm. 2013. PMID: 22937971

6

Interactions of inhibitor molecules with the human CYP2E1 enzyme active site.

Martikainen LE, Rahnasto-Rilla M, Neshybova S, Lahtela-Kakkonen M, Raunio H, Juvonen RO. Martikainen LE, et al. Among authors: raunio h. Eur J Pharm Sci. 2012 Dec 18;47(5):996-1005. doi: 10.1016/j.ejps.2012.09.018. Epub 2012 Oct 13. Eur J Pharm Sci. 2012. PMID: 23069620

7

Inhibitory effects and oxidation of 6-methylcoumarin, 7-methylcoumarin and 7-formylcoumarin via human CYP2A6 and its mouse and pig orthologous enzymes.

Juvonen RO, Kuusisto M, Fohrgrup C, Pitkänen MH, Nevalainen TJ, Auriola S, Raunio H, Pasanen M, Pentikäinen OT. Juvonen RO, et al. Among authors: raunio h. Xenobiotica. 2016;46(1):14-24. doi: 10.3109/00498254.2015.1048327. Epub 2015 Jun 11. Xenobiotica. 2016. PMID: 26068522

8

Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.

Raunio H, Juvonen RO, Poso A, Lahtela-Kakkonen M, Rahnasto-Rilla M. Raunio H, et al. Drug Metab Lett. 2016;10(1):56-64. doi: 10.2174/1872312810666151204002456. Drug Metab Lett. 2016. PMID: 26648056

9

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors.

Rauhamäki S, Postila PA, Niinivehmas S, Kortet S, Schildt E, Pasanen M, Manivannan E, Ahinko M, Koskimies P, Nyberg N, Huuskonen P, Multamäki E, Pasanen M, Juvonen RO, Raunio H, Huuskonen J, Pentikäinen OT. Rauhamäki S, et al. Among authors: raunio h. Front Chem. 2018 Mar 2;6:41. doi: 10.3389/fchem.2018.00041. eCollection 2018. Front Chem. 2018. PMID: 29552556 Free PMC article.

10

Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.

Juvonen RO, Jokinen EM, Javaid A, Lehtonen M, Raunio H, Pentikäinen OT. Juvonen RO, et al. Among authors: raunio h. Chem Biol Drug Des. 2020 May;95(5):520-533. doi: 10.1111/cbdd.13669. Epub 2020 Mar 9. Chem Biol Drug Des. 2020. PMID: 32060993 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page